Discussion Boards => Main Discussion Board => Topic started by: GoingNuts on June 16, 2017, 06:35:39 AM
FAS has upgraded our forum security. Some members may need to log in again. If you are unable to remember your login information, please email food.allergy.supt@flash.net and we will help you get back in. Thanks for your patience!
Title: FDA Approves Competitor to EpiPen - Less Expensive, Smaller
Post by: GoingNuts on June 16, 2017, 06:35:39 AM
Non-autoinjector means there's also a bigger accidental prick/injection in unintended body part risk both before and after injection (especially after - EpiPen orange cap moves to cover needle as it is removed and Auvi-Q auto retracts).
Curious to see what the price point will be on Symjepi, it may help put downward price pressure on everything else if it's cheap enough.
Case looks big as does autoinjector, but without scale (they say the syringe fits in the palm of an adult) it's hard to gauge.
I think Windgap Medical's version of an autoinjector holds the most promise, if it can make it to market (they hope to apply to FDA in 2018). It's solid until the cap is removed, at which point the solution rehydrates to a solid. Meaning it tolerates a lot more temperature/handling conditions than liquid epinephrine in something "the size of a roll of quarters", with a much longer lifespan than liquid epinephrine too (years, not a year).
Title: Re: FDA Approves Competitor to EpiPen - Less Expensive, Smaller
Post by: SilverLining on June 20, 2017, 08:08:50 PM
With swing and press (current instructions on epipen.ca site) it is easy to inject in the wrong place or wrong person. If you don't have another adult to hold the child, they can and have pulled their leg away.
And was it someone from here, or an article posted, that someone injected the epi into their own boob?
I agree an autoinjecter is easier and preferable. But for anyone without insurance, this could be a good option. Definitely better than a vial and needle. And definitey better than the Anakit.